Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
1T32CA075930-01
Application #
2433779
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
1998-02-24
Project End
2003-01-31
Budget Start
1998-02-24
Budget End
1999-01-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Alberti, M O; Deshane, J S; Chaplin, D D et al. (2013) A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism. Gene Ther 20:733-41
Cody, James J; Rivera, Angel A; Lyons, Gray R et al. (2013) Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. Lab Invest 93:268-78
Alberti, Michael O; Roth, Justin C; Ismail, Mourad et al. (2012) Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation. PLoS One 7:e37812
Yang, Sherry W; Chanda, Diptiman; Cody, James J et al. (2011) Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer. PLoS One 6:e25131
Wang, Wei; Rayburn, Elizabeth R; Velu, Sadanandan E et al. (2010) A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action. Breast Cancer Res Treat 123:321-31
Cody, J J; Rivera, A A; Lyons, G R et al. (2010) Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. Cancer Gene Ther 17:893-905
Wang, Feng; Ezell, Scharri J; Zhang, Yong et al. (2010) FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer. Invest New Drugs 28:234-41
Gamble, Lena J; Borovjagin, Anton V; Matthews, Qiana L (2010) Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review). Exp Ther Med 1:233-240
Thacker, Erin E; Nakayama, Masaharu; Smith, Bruce F et al. (2009) A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo. Vaccine 27:7116-24
Skipper, Joni B; McNally, Lacey R; Rosenthal, Eben L et al. (2009) In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec 71:1-5

Showing the most recent 10 out of 42 publications